Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center.
Fausto RosaFederica GaliandroRiccardo RicciDario Di MiceliFabio LongoGiuseppe QueroAntonio Pio TortorelliSergio AlfieriPublished in: Langenbeck's archives of surgery (2021)
Patients with AGC undergoing surgery plus HIPEC had a better OS and DFS with respect to patients treated with surgery alone.